Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Asset Resilience Ratio
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A asset resilience ratio. Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has an Asset Resilience Ratio of 7.64% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shanghai Shenqi Pharmaceutical Investmen liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1993–2025)
Asset resilience ratio of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 1993 to 2025. This chart shows how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's Asset Resilience Ratio has changed over time. Read how much debt does Shanghai Shenqi Pharmaceutical Investmen carry for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 600613 total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥232.70 Million | 7.64% |
| Total Liquid Assets | CN¥232.70 Million | 7.64% |
Asset Resilience Insights
- Limited Liquidity: Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A maintains only 7.64% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Industry Peers by Asset Resilience Ratio
Compare Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Novartis AG
SW:NOVN |
Drug Manufacturers - General | 0.08% |
|
AstraZeneca PLC
NASDAQ:AZN |
Drug Manufacturers - General | 0.10% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 5.33% |
|
Novartis AG
MX:NVSN |
Drug Manufacturers - General | 0.08% |
|
Biogen Inc
NASDAQ:BIIB |
Drug Manufacturers - General | 0.00% |
|
Organon & Co
NYSE:OGN |
Drug Manufacturers - General | 4.46% |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
Drug Manufacturers - General | 0.53% |
|
GuangYuYuan Chinese Herbal Medicine Co Ltd
SHG:600771 |
Drug Manufacturers - General | 1.97% |
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Asset Resilience Ratio by Year (1993–2025)
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A asset resilience ratio by year from 1993 to 2025. The table below shows the annual Asset Resilience Ratio data for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 3.51% | CN¥110.40 Million ≈ $16.15 Million |
CN¥3.15 Billion ≈ $460.23 Million |
+2.84pp |
| 2024-12-31 | 0.67% | CN¥20.87 Million ≈ $3.05 Million |
CN¥3.12 Billion ≈ $455.94 Million |
+0.03pp |
| 2023-12-31 | 0.64% | CN¥20.90 Million ≈ $3.06 Million |
CN¥3.28 Billion ≈ $479.87 Million |
+0.56pp |
| 2008-12-31 | 0.08% | CN¥200.00K ≈ $29.27K |
CN¥261.87 Million ≈ $38.32 Million |
-0.13pp |
| 2005-12-31 | 0.20% | CN¥595.54K ≈ $87.15K |
CN¥294.59 Million ≈ $43.11 Million |
+0.17pp |
| 2000-12-31 | 0.03% | CN¥151.55K ≈ $22.18K |
CN¥530.13 Million ≈ $77.57 Million |
-0.01pp |
| 1999-12-31 | 0.04% | CN¥184.97K ≈ $27.07K |
CN¥486.20 Million ≈ $71.15 Million |
+0.03pp |
| 1998-12-31 | 0.01% | CN¥91.55K ≈ $13.40K |
CN¥747.54 Million ≈ $109.39 Million |
0.00pp |
| 1997-12-31 | 0.02% | CN¥91.55K ≈ $13.40K |
CN¥576.22 Million ≈ $84.32 Million |
-0.20pp |
| 1996-12-31 | 0.22% | CN¥1.12 Million ≈ $163.97K |
CN¥518.43 Million ≈ $75.86 Million |
-1.34pp |
| 1995-12-31 | 1.56% | CN¥7.62 Million ≈ $1.12 Million |
CN¥489.14 Million ≈ $71.58 Million |
+1.35pp |
| 1994-12-31 | 0.21% | CN¥1.02 Million ≈ $149.11K |
CN¥485.73 Million ≈ $71.08 Million |
-2.86pp |
| 1993-12-31 | 3.07% | CN¥12.93 Million ≈ $1.89 Million |
CN¥420.63 Million ≈ $61.55 Million |
-- |
About Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fiel… Read more